Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Feb 15, 2023; 15(2): 268-275
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.268
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.268
Radiology | Serology | Histology | Response to steroid |
Parenchyma:Diffuse enlargement with enhancement | IgG4 > 2 x upper limit of normal value | At least three | < 2 wk radiologically demonstrable resolution or marked improvement pancreatic/extrapancreatic manifestations |
Duct: > 1/3 length of the main pancreatic duct | Periductal lymphoplasmacytic infiltrate without granulocytic infiltration | ||
Atypical: Segmental/focal narrowing with duct < 5 mm | Storiform fibrosis | ||
Other organ involvement: Bile duct: Segmental/multiple proximal or distal stricture | Obliterative phlebitis | ||
Retroperitoneal fibrosis | > 10 IgG4-positive cells/high power field | ||
Salivary/lachrymal glands: Symmetrically enlarged | |||
Renal involvement |
- Citation: Caba O, Diéguez-Castillo C, Martínez-Galán J, González-Cebrián I, Jiménez-Luna C. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma. World J Gastrointest Oncol 2023; 15(2): 268-275
- URL: https://www.wjgnet.com/1948-5204/full/v15/i2/268.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.268